Natco Pharma Limited has informed the Exchange regarding a press release dated November 12, 2020, titled "Press Release on the Financial Results for the Quarter and Half Year ended September 30, 2020".
Press Release Nov 12 2020
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from NATCO Pharma
- Press Release Sep 30 2020
- NATCO Pharma records INR 582.1 Crore consolidated revenue and INR 122.1 Crore of profit, after tax, for the First Quarter, FY2020-21
Later from NATCO Pharma
- Press Release Nov 13 2020
- NATCO Pharma receives Pomalidomide approval for US market
- Press Release Dec 17 2020
- NATCO Pharma launches anti blood clot tablet Rivaroxaban in India
- Press Release Feb 05 2021
Follow NATCO Pharma into a list and get an email when it puts out news.
Follow NATCO Pharma